| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |